PUBLIC CONTRACT · 2025
Aquisição de SEVOFLURANO, INA, 250 MG, SOL FR, ao abrigo do CPA 2022/19, para a ULSASI, para o ano 2025, 2026 e 2027
- Contract value
- €105,400.00
- Signed on
- 16 May 2025
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 11446578PUBLISHED SUBJECT
Aquisição de SEVOFLURANO, INA, 250 MG, SOL FR, ao abrigo do CPA 2022/19, para a ULSASI, para o ano 2025, 2026 e 2027
Parties involved
- Place of performance
- Portugal, Lisboa, Amadora
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- BAXTER MEDICO – FARMACEUTICA · Tax ID 503347345
Values and timeline
- Contract price
- €105,400.00
- Procedure base price
- €127,500.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 16 May 2025
- Award date
- 15 May 2025
- Signing date
- 16 May 2025
- Performance period
- 1,096 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- CP 2022/19 - Medicamentos antipsicóticos, anestésicos e relaxantes musculares
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7634834
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.